What is Supernus Pharmaceuticals's current inventory?

Supernus Pharmaceuticals (SUPN) reported current inventory of $87.06M in Q1 2026.

What does current inventory mean?

This represents the total value of raw materials, work-in-progress, and finished pharmaceutical products held by the company. It serves as a critical indicator of supply chain health and the company's ability to meet anticipated market demand for its neuroscience portfolio. High levels may indicate potential overstocking or slow-moving products, while low levels could signal supply chain constraints or production bottlenecks.

Supernus Pharmaceuticals SUPN Current inventory

Current inventory at other companies

United TherapeuticsUTHR

$178.3M+7.8%

BiogenBIIB

$139.5M+18.8%

Bristol-Myers SquibbBMY

$2.76B+3.4%

Corcept TherapeuticsCORT

$14.51M+1,144%

Eli LillyLLY

$14.49B+56.1%

Neurocrine BiosciencesNBIX

$64.7M+9.1%

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept supn:InventoryCurrent.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's current inventory.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's current inventory?: Supernus Pharmaceuticals (SUPN) reported current inventory of $87.06M in Q1 2026.
What does current inventory mean?: This represents the total value of raw materials, work-in-progress, and finished pharmaceutical products held by the company. It serves as a critical indicator of supply chain health and the company's ability to meet anticipated market demand for its neuroscience portfolio. High levels may indicate potential overstocking or slow-moving products, while low levels could signal supply chain constraints or production bottlenecks.